An Exploratory Prospective, Open-label, Unicentric Study With Cross-over Design, Comparing Lymphoseek vs. Albumin Nanocolloid for Image- Guided Sentinel Lymph Node Mapping in Head and Neck, Melanoma and Breast Cancer
Latest Information Update: 03 Feb 2022
At a glance
- Drugs Tc 99m tilmanocept (Primary) ; Technetium Tc 99m nanocolloid (Primary)
- Indications Ductal carcinoma; Early breast cancer; Head and neck cancer; Malignant melanoma; Mouth neoplasm; Squamous cell cancer
- Focus Diagnostic use
- Acronyms SENTINELSEEK
- 14 Feb 2020 New trial record